Join
Live feed
·
INSIDERFilingvia Quantisnow
VolitionRX Limited logo

President and CEO Reynolds Cameron John was granted 486,000 shares, increasing direct ownership by 18% to 3,115,547 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VNRX· VolitionRX Limited
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VNRX (VolitionRX Limited) and more on Quantisnow.